Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Ascencio Sca | ASCE | 5. nov 2024 | 46.10 | +0.55 |
ASIT biotech SA | ASIT | 5. nov 2024 | 0.23 | 0.00 |
Assicurazioni Generali SpA | GEN | 5. nov 2024 | 19.50 | 0.00 |
Atenor | ATEB | 5. nov 2024 | 4.33 | -0.57 |
AVANTIUM | AVTX | 5. nov 2024 | 2.36 | +0.64 |
Azelis Group NV | AZE | 5. nov 2024 | 18.15 | -1.52 |
Balta Group N.V. | BALTA | 5. nov 2024 | 1.36 | 0.00 |
Banco Bilbao Vizcaya Argentaria SA | BBV | 5. nov 2024 | 7.80 | 0.00 |
Banco Santander SA | SANTA | 5. nov 2024 | 3.58 | 0.00 |
Banimmo SA | BANI | 5. nov 2024 | 2.98 | -0.67 |
Banque Nationale de Belgique | BNB | 5. nov 2024 | 413.00 | +0.73 |
Barco NV | BAR | 5. nov 2024 | 11.54 | +0.70 |
Basilix | BAS | 5. nov 2024 | 24.80 | 0.00 |
Beaulieu Av Certificates | BEAB | 5. nov 2024 | 1.19 | 0.00 |
Befimmo SA | BEFB | 5. nov 2024 | 46.10 | 0.00 |
Bel20 | BEL20 | 5. nov 2024 | 4 267.16 | +0.71 |
Belreca - Belgian Resources and Capital Company | BELR | 5. nov 2024 | 7.50 | 0.00 |
Beluga NV | BELU | 5. nov 2024 | 1.50 | 0.00 |
Belysse Group N.V. | BELYS | 5. nov 2024 | 0.78 | +1.31 |
Biocartis Group NV | BCART | 5. nov 2024 | 0.29 | 0.00 |
Biosenic | BIOS | 5. nov 2024 | 0.01 | 0.00 |
Biotalys | BTLS | 5. nov 2024 | 3.10 | +0.65 |
Boeing | BOEI | 5. nov 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | 5. nov 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | 5. nov 2024 | 2.31 | -0.64 |
Brederode S.A. | BREB | 5. nov 2024 | 106.00 | +0.95 |
Campine nv | CAMB | 5. nov 2024 | 83.50 | 0.00 |
Candela Invest | CAND | 5. nov 2024 | 1.20 | 0.00 |
Care Property Invest NV/SA | CPINV | 5. nov 2024 | 12.16 | +0.83 |
Celyad Oncology SA | CYAD | 5. nov 2024 | 0.37 | +5.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.